Author
Listed:
- Andria Mousa
- Gina Cuomo-Dannenburg
- Hayley A Thompson
- R Matthew Chico
- Khalid B Beshir
- Colin J Sutherland
- David Schellenberg
- Roly Gosling
- Michael Alifrangis
- Emma Filtenborg Hocke
- Helle Hansson
- Ana Chopo-Pizarro
- Wilfred F Mbacham
- Innocent M Ali
- Mike Chaponda
- Cally Roper
- Lucy C Okell
Abstract
Background: Recently revised WHO guidelines on malaria chemoprevention have opened the door to more tailored implementation. Countries face choices on whether to replace old drugs, target additional age groups, and adapt delivery schedules according to local drug resistance levels and malaria transmission patterns. Regular routine assessment of protective efficacy of chemoprevention is key. Here, we apply a novel modelling approach to aid the design and analysis of chemoprevention trials and generate measures of protection that can be applied across a range of transmission settings. Methods and findings: We developed a model of genotype-specific drug protection, which accounts for underlying risk of infection and circulating genotypes. Using a Bayesian framework, we fitted the model to multiple simulated scenarios to explore variations in study design, setting, and participant characteristics. Conclusions: These findings have important implications for the current guidelines on chemoprevention efficacy studies and will be valuable for informing where these studies should be optimally placed. The results underscore the need for a comparator group in seasonal settings and provide evidence that the extension of follow-up in single-arm trials improves the accuracy of measures of protective efficacy in settings with more stable transmission. Extension of follow-up may pose logistical challenges to trial feasibility and associated costs. However, these studies may not need to be repeated multiple times, as the estimates of drug protection against different genotypes can be applied to different settings by adjusting for transmission intensity and frequency of resistance. Using a novel modelling approach, Mousa and colleagues investigate the design and analysis of malaria chemoprevention trials and generate measures of protection that can be applied across a range of transmission settings.Why was this study done?: What did the researchers do and find?: What do these findings mean?:
Suggested Citation
Andria Mousa & Gina Cuomo-Dannenburg & Hayley A Thompson & R Matthew Chico & Khalid B Beshir & Colin J Sutherland & David Schellenberg & Roly Gosling & Michael Alifrangis & Emma Filtenborg Hocke & Hel, 2024.
"Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodology,"
PLOS Medicine, Public Library of Science, vol. 21(5), pages 1-18, May.
Handle:
RePEc:plo:pmed00:1004376
DOI: 10.1371/journal.pmed.1004376
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pmed00:1004376. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosmedicine (email available below). General contact details of provider: https://journals.plos.org/plosmedicine/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.